Executive Biographies & Photos
William F. Feehery, Ph.D.
Dr. William F. Feehery is president, DuPont Industrial Biosciences.
Dr. Feehery joined DuPont Industrial Biosciences in November 2013, where he leads a global team of more than 2,500 with revenues surpassing $2B. Industrial Biosciences is a world leader in industrial enzymes, biomaterials, biofuels, and environmental technologies. It serves diverse markets including home & personal care, grain processing, food, animal nutrition, fabric/textiles and oil/gas/chemical production.
He began his career at DuPont in 2002, working in various businesses throughout the company including DuPont Displays where he helped develop advanced technology and materials for cost-efficient OLED displays as well as Digital Printing, Display Enhancements and Authentications. Feehery was named global business director for DuPont Photovoltaic Solutions in 2011, and led the company’s growth and expansion as the world leader in materials for solar energy.
Prior to joining DuPont, Dr. Feehery worked in venture capital and was a management consultant with the Boston Consulting Group. He graduated from the University of Pennsylvania with a degree in chemical engineering and studied at Cambridge University as a Winston Churchill Scholar. He received both his doctorate in chemical engineering and an MBA from the Massachusetts Institute of Technology.
Dr. Feehery is a board member of West Pharmaceutical Services. He is also a member of the visiting committee for the MIT Department of Chemical Engineering.
Michael V. Arbige, Ph.D.
Dr. Michael V. Arbige is Vice President of Research and Development at DuPont Industrial Biosciences.
Prior to his current role, Dr. Arbige held the position of executive vice president of Technology, for Genencor, a Danisco Division. Since joining Genencor in 1982, he has served in many roles including senior scientist, director of Fermentation and Process Recovery, vice president of Development, and vice president of Research.
He received his Bachelor of Science degree in Microbiology from the University of Rhode Island in 1977 followed by his PhD in 1982 in the field of Microbial Physiology and Genetics from the University of New Hampshire.
Dr. Arbige joined Genencor as one of its first employees. During his early tenure at Genencor, Dr. Arbige played a lead role in the development of the first series of recombinant and protein engineered protein products ever to enter the industrial marketplace. Since that time Dr. Arbige has been involved in the commercialization of hundreds of protein based products and has helped establish laboratory and production facilities around the world.
Dr. Arbige currently serves on the boards of Solazyme & Butamax as well as serving for the past 15 years on the board of BayBio, most notably as a past chair and executive member. He is on the technical steering team of DuPont Cellulosic Ethanol and belongs to numerous technical societies including Industrial Research Institute (IRI), American Chemical Society (ACS), American Association of Microbiology (ASM) and Society for Industrial Microbiology(SIM).
Michael A. Saltzberg, Ph.D.
Dr. Michael A. Saltzberg is Global Business Director of Biomaterials at DuPont Industrial Biosciences.
As Global Business Director for Biomaterials, Dr. Saltzberg leads the development of a portfolio of emerging and growth businesses which utilize renewable feedstocks to make industrially important chemicals and materials. Through the development of renewable biochemical and biomaterials, Saltzberg and solve critical issues for industries as varied as packaging and cosmetics to apparel and carpeting, all facing the challenges of greening their supply chains and offering sustainable choices to their downstream customers.
Saltzberg is a prominent voice in the advanced biomaterials space – as Global Business Director Saltzberg has been a featured speaker in a variety of conferences. He’s headlined a panel at SXSW Eco where he discussed the promise and practicality of biomaterials (link) and spoke at spoke at The Economist’s Future of Materials Summit.
Mike is a veteran of the industry with over twenty-eight years of experience at DuPont including R&D management, sales & marketing, and business development. He has led DuPont’s efforts in Biomaterials business development since 2006.
Dr. Saltzberg is a native of Philadelphia, Pa. He holds a B.A. with Honors in Chemistry from Oberlin College and a Ph.D. in Materials Science and Engineering from the University of Pennsylvania.
Simon Herriott leads DuPont’s Global Bioactives (enzymes) business and serves on DuPont Industrial Biosciences Senior Leadership team. Bringing DuPont’s world-leading biotechnology capabilities to a wide variety of specialty markets, Simon is focused on achieving excellence in delivering a rich new product portfolio to match pressing societal, industry and customer-specific needs.
Prior to his current role he led DuPont’s biomaterials business for two years including the development of Sorona® renewably-sourced fibers for textiles and DuPont’s extensive R&D portfolio in renewable materials.
Between 2011 and 2014, Simon led the global consulting business for DuPont Sustainable Solutions, including practices in safety, environmental management, energy efficiency, operations and capital performance and learning & development.
Simon’s background is in international business leadership, strategy, marketing and organizational development and he has 30 years’ experience in the global chemical industry. He has lived and worked in Europe, USA and Asia and now resides in Philadelphia, USA
Eli Ben-Shoshan is Global Business Director, DuPont Clean Technologies (a division of DuPont Industrial Biosciences). Previously Eli was Director, Strategy and M&A, for DuPont Industrial Biosciences. Prior to joining DuPont in February 2012, Eli was Managing Director, Priolytics, where he worked primarily for his key client, Genencor (acquired via the DuPont acquisition of Danisco in 2011), in a business development capacity.
Eli’s career spans strategy, finance, business development and business leadership with a primary focus in chemicals, biotechnology and related industries. He served as Vice President, Business Development, Kraton Polymers; Vice President, Negotiation Solutions, ChemConnect / CheMatch; Director Finance & Business Development, Koch Industries / KoSa; and Strategy Consultant, Monitor Company.
Eli holds Bachelor’s degrees in Physics and Economics and an MBA all from Stanford University. He is also a licensed CPA.